[Clinical effect of cefotetan against infectious diseases in obstetrics and gynaecology].
Clinical study on cefotetan (CTT), a new cephamycin antibiotic, was carried out and the following results were obtained. CTT was intravenously administered at a daily dose of 2 to 4 g to 24 cases including 10 cases with intrauterine infection, 2 cases with adnexitis, 6 cases with intrapelvic infection and 6 cases with extragenital infection. Marked response was seen in 8 cases, moderate response in 15 and no response in 1. Neither side effects nor abnormal values in clinical laboratory tests were observed.
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D015313:Cefotetan; D002513:Cephamycins / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged
D002513:Cephamycins; D015313:Cefotetan